Home Stock

Stock Research: Formosa Laboratories

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Formosa Laboratories

TAI:4746 TW0004746003
63
  • Value
    45
  • Growth
    51
  • Safety
    Safety
    65
  • Combined
    53
  • Sentiment
    68
  • 360° View
    360° View
    63
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Formosa Laboratories, Inc. develops, produces, and distributes UV-proof active ingredients and pharmaceutical chemicals. It operates in the pharmaceutical industry, specializing in UV-proof active ingredients, vitamin D derivatives, anti-inflammatory analgesics, and more. The company distributes its products to Europe, the Americas, and Asia. In the last fiscal year, the company had a market cap of $281 million, profits of $62 million, and revenue of $144 million. The number of employees is not available.

more

ANALYSIS: With an Obermatt 360° View of 63 (better than 63% compared with alternatives), overall professional sentiment and financial characteristics for the stock Formosa Laboratories are above average. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Formosa Laboratories. The consolidated Growth Rank has a good rank of 51, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 51% of competitors in the same industry. The consolidated Safety Rank at 65 means that the company has a financing structure that is safer than 65% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 68, which means that professional investors are more optimistic about the stock than for 68% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 45, meaning that the share price of Formosa Laboratories is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 55% of alternative stocks in the same industry. ...read more

more
Strongest Rank Dividend Yield
Weakest Rank Profit Growth
Country Taiwan
Industry Pharmaceuticals
Size Small
Website formosalab.com
Index
Formosa Laboratories stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 9-Apr-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
45 84 76 93
Growth
51 70 89 61
Safety
Safety
65 30 24 18
Sentiment
68 80 80 70
360° View
360° View
63 89 92 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
62 90 87 66
Opinions Change
50 50 6 50
Pro Holdings
n/a 84 66 94
Market Pulse
77 33 100 n/a
Sentiment
68 80 80 70
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
45 84 76 93
Growth
51 70 89 61
Safety Safety
65 30 24 18
Combined
53 75 82 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
57 50 43 56
Price vs. Earnings (P/E)
64 93 81 97
Price vs. Book (P/B)
77 57 51 84
Dividend Yield
1 98 91 83
Value
45 84 76 93
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
42 68 92 75
Profit Growth
89 96 8 3
Capital Growth
33 58 92 33
Stock Returns
43 12 83 95
Growth
51 70 89 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
37 22 21 12
Refinancing
61 53 47 51
Liquidity
77 40 30 12
Safety Safety
65 30 24 18

Similar Stocks

Discover high‑ranked alternatives to Formosa Laboratories and broaden your portfolio horizons.

Kinden

TYO:1944
Country: Japan
Industry: Construction & Engineering
Size: X-Large
Full Stock Analysis

Shionogi

TYO:4507
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Sinopharm

HKG:1099
Country: China
Industry: Health Care Distributors
Size: X-Large
Full Stock Analysis

Simplo Technology

TWO:6121
Country: Taiwan
Industry: Electronic Components
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews